1. bookVolume 9 (2018): Issue 1 (January 2018)
Journal Details
License
Format
Journal
eISSN
1891-5469
First Published
01 Jan 2010
Publication timeframe
1 time per year
Languages
English
access type Open Access

Estimation of body composition and water data depends on the bioelectrical impedance device

Published Online: 31 Dec 2018
Volume & Issue: Volume 9 (2018) - Issue 1 (January 2018)
Page range: 96 - 105
Received: 10 Sep 2018
Journal Details
License
Format
Journal
eISSN
1891-5469
First Published
01 Jan 2010
Publication timeframe
1 time per year
Languages
English
Abstract

Overweight, obese and chronic kidney disease patients have an altered and negative body composition being its assessment important. Bioelectrical impedance analysis is an easy-to-operate and low-cost method for this purpose. This study aimed to compare and correlate data from single- and multi-frequency bioelectrical impedance spectroscopy applied in subjects with different body sizes, adiposity, and hydration status. It was a cross-sectional study with 386 non-chronic kidney disease volunteers (body mass index from 17 to 40 kg/m2), 30 patients in peritoneal dialysis, and 95 in hemodialysis. Bioelectrical impedance, body composition, and body water data were assessed with single- and multi-frequency bioelectrical impedance spectroscopy. Differences (95% confidence interval) and agreements (Bland-Atman analyze) between devices were evaluated. The intraclass correlation coefficient was used to measure the strength of agreement and Pearson’s correlation to measure the association. Regression analyze was performed to test the association between device difference with body mass index and overhydration. The limits of agreement between devices were very large. Fat mass showed the greatest difference and the lowest intraclass and Pearson’s correlation coefficients. Pearson’s correlation varied from moderate to strong and the intraclass correlation coefficient from weak to substantial. The difference between devices were greater as body mass index increased and was worse in the extremes of water imbalance. In conclusion, data obtained with single- and multi-frequency bioelectrical impedance spectroscopy were highly correlated with poor agreement; the devices cannot be used interchangeably and the agreement between the devices was worse as body mass index and fat mass increased and in the extremes of overhydration.

Keywords

Introduction

Overweight and obese individuals have a body composition similar to those with chronic kidney disease (CKD): increased body fat sometimes added to lean mass depletion [1,2]. These conditions have a negative effect on physical capacity and are related to a higher risk of mortality [1,3] and lower life expectancy [4]. Thus, body composition assessment is important for these subjects.

However, presence of edema and excess fat limit the application of classic methodologies, such as anthropometry [5]. Moreover, reference methods are expensive, time-consuming, and have low availability [5,6]. Therefore, bioelectrical impedance analyze is a promising method for body composition assessment as it is easy to operate, of low cost, and with good accuracy rates [5,7,8,9,10,11,12].

Several bioelectrical impedance methods exist, including single-frequency bioelectrical impedance analyze (SFBIA) and multi-frequency bioelectrical impedance spectroscopy (BIS) [8]. Because the devices are different in the range of frequencies and mathematical approaches applied for body composition and water estimation [7,9,10,11,13], the agreement between their measures is unclear.

Therefore, we investigated whether the use of different bioelectrical impedance devices influence the estimation of body composition and water data in a population with different body sizes, adiposity, and hydration status; factors that influences the difference between methods were also assessed.

Materials and methods

This study evaluated the data from 3 cross-sectional observational studies, including 386 non-CKD volunteers (professionals working at a university hospital, undergraduate students, and graduate students, 204 females and 182 males, aged from 20 to 40 years); 30 patients undergoing peritoneal dialysis (PD) treatment; and 93 patients in haemodialysis (HD) treatment. Both groups of patients were under treatment for at least 3 months, 53 were females and 70 males, aged from 15 to 81 years, recruited from a tertiary care hospital.

Convenience sampling was used to contact and screen potential candidates: for the non-CKD group, all subjects interested in participating and within the criteria of eligibility were evaluated. From the 36 initial PD outpatients, 3 were ineligible and 3 refused to participate. From the 310 HD patients, 162 were ineligible and 55 refused to participate.

Exclusion criteria for the non-CKD group were metabolic and/or endocrine diseases and use of medication known to influence body composition and for CKD groups, diseases that influence body composition other than CKD and presence of peritonitis in the last 30 days prior to assessment. For all groups, subjects with pregnancy, lactation, infectious diseases, inflammatory state, amputation, presence of prosthesis or pacemaker were excluded.

The 3 studies were conducted in accordance with the Declaration of Helsinki and received the approval of the Medical School Clinical Hospital Ethical Committee (protocols number 1076550, 931621 and 1036622). All participants provided written informed consent prior to the initiation of the study procedures. Moreover, this study was in accordance with STROBE guidelines for observational studies.

All measurements were performed according to standardized conditions on the same day, by a trained and experienced dietitian, early in the morning after a fasting period of 12 h [8]. For the HD group, the fasting period was of 2 h. Measurements were always made with a drained abdominal cavity and up to 15 minutes after HD mid-week session.

Clinical data from non-CKD and CKD groups were obtained through interviews and medical records, respectively. Patients in the PD group were under automated PD (60%) or continuous ambulatory PD (40%). Patients in HD were treated through arteriovenous fistula, three times a week with 4-h sessions. The criteria used for diagnosis of CKD, diabetes mellitus (DM), and systemic arterial hypertension (SAH) were those proposed by the National Kidney Foundation [14], American Diabetes Association [15] and the NICE guideline [16], respectively. Residual diuresis classification was applied as previously proposed [17].

Body weight and height were measured according to Heymsfield using a platform beam scale with a built-in stadiometer (ID 1500, Filizola) [18]. BMI was calculated and used for stratifying the non-CKD group [19].

BIS (BCM, Fresenius) and SFBIA (Quantum II, RJL Systems, for the non-CKD group; TBW, Biodynamics, for CKD groups) were applied in random order and both in hand-to-foot tetrapolar position [8]. Unless a fistula was present, the right side was used and measurements were done after being in supine position for 20 min. Using resistance (R) and reactance (Xc) from BIS, intracellular water (ICW) and extracellular water (ECW) [10], fat free mass (FFM), and fat mass (FM) [13] were estimated applying predictive equations previously developed. Total body water (TBW) was calculated by the sum of ICW and ECW. The appropriate predictive equations were used for SFBIA data to calculate ECW [20], FFM [21] and TBW [21] for non-CKD group, FFM for PD [22] and for HD [23] groups and TBW [23] for CKD groups. FM was calculated as weight minus FFM and ICW as TBW minus ECW. The nutritional status was assessed by phase angle (PA) obtained by BIS analyse according to Kuchnia and collaborators [24]. Hyperhydration and dehydration were determined by overhydration (OH) values of > 1.1 L and ≤1.1 L [25], respectively obtained with the BIS device, as SFBIA is unable to provide such information. For descriptive data of body composition and nutritional status BIS data was used.

Data are presented as mean ± SD, minimum, maximum and frequency values. We applied Q-Q plot to analyze data distribution [26], the unpaired t-test for comparison between CKD groups, and ANOVA for comparison between non-CKD and CKD groups [27]. Differences between devices were evaluated as the difference between BIS and SFBIA (BIS – SFBIA). The 95% confidence interval (95%CI) for mean difference was calculated: if the interval included zero, the data measured with the 2 devices agreed on group level. Agreement on individual level was evaluated using Bland-Altman analyze with limits of agreement [28]. We applied intraclass correlation coefficient (ICC) to measure the strength of agreement and Pearson’s correlation to assess the association as previously proposed [29,30]. Regression analyze was performed to test the association between agreement with BMI and OH. Statistical significance was considered when p<0.05. Data analyze were performed using MINITAB, version 18.

Results

A total of 509 subjects were evaluated. Descriptive data are shown in Table 1. PD (43% ≥60 years old) and HD (23% ≥60 years old) groups were older than the non-CKD group. Weight, FM, and FMI significantly increased with increasing BMI subgroups. The PD group was classified according to BMI as 3% underweight, 40% overweight, and 3% obese and the HD group as 3, 31 and 19%, respectively for the same categories. The FFM and FFMI were similar between CKD groups and the underweight subgroup. PD and HD groups were similar to overweight subgroup for FM and FMI.

Descriptive data for non-CKD subjects stratified in BMI subgroups and for CKD patients stratified in PD and HD subgroups

BMI<18.518.5≤BMI<2525≤BMI<30BMI≥30PDHD
n401201181083093
Women (%)326259521142
(80)(51)(50)(48)(37)(45)
Age (years)26±4.2a29±3.9a29±4.6a30±5a52±19b47±13c
(20 to 38)(20 to 40)(20 to 40)(20 to 40)(15 to 81)(20 to 76)
Weight (kg)48±4.9a64±9.4b79±9.8c98±12d68±13be72±17e
(39 to 60)(45 to 87)(59 to 109)(71 to 124)(38 to 93)(42 to 137)
BMI (kg/m2)18±0.7a22±1.8b27±1.4c34±2.7d24±3.4e26±5e
(15 to 18)(19 to 25)(25 to 30)(30 to 40)(16 to 32)(17 to 44)
OH (L)-0.1±0.4a-0.3±0.7a-0.5±0.9ab-0.8±0.9b2.1±2.2c-0.9±1.9b
(-1.2 to 0.9)(-1.9 to 1.5)(-3.1 to 2.1)(-3 to 1.8)(-0.7 to 6.2)(-5 to 6.0)
OH>1.1 L (%)00431710
(0)(0)(3)(3)(57)(11)
OH<-1.1 L (%)0142942049
(0)(12)(25)(39)(0)(53)
FFM (kg)34±6.3a43±11b45±13b46±13b34±6.6a38±9.7a
(26 to 51)(26 to 70)(27 to 76)(25 to 76)(24 to 56)(20 to 60)
FFMI (kg/m2)12±1.5a15±2.8b15±3.1b15±3.1b12±1.8a14±2.6a
(10 to 16)(9 to 22)(10 to 23)(9 to 23)(8 to 16)(8 to 20)
FM (kg)14±4a21±7.1b34±9.3c52±12d30±12c34±16c
(4 to 21)(3 to 37)(11 to 57)(24 to 83)(9 to 56)(2 to 99)
FMI (kg/m2)5±1.5a7±2.7b12±3.5c18±4.6d11±4.2c12±5.6c
(1 to 8)(1 to 13)(4 to 19)(8 to 29)(4 to 19)(1 to 29)
PA ()5.8±0.5a6.6±0.8b6.8±0.8b6.8±0.8b4.7±1.1c6.1±1.2a
(4.8 to 7)(4.8 to 8.2)(5.3 to 9)(5 to 8.9)(2.8 to 7.1)(3 to 9.1)
Impairment Nutritional status (%)147422333
(10)(6)(3)(2)(76)(36)
DM (%)00001061
(0)(0)(0)(0)(33)(66)
SAH (%)00001961
(0)(0)(0)(0)(63)(66)
Residual Diuresis (ml)2937±680***170±330***
(50 to 2000)(0 to 2000)
Kt/V12.6±0.9***1.5±0.3***
(1.4 to 4.5)(1 to 2.5)
Duration of dialytic treatment33±32***63±48***
(months)2(3 to 144)(5 to 264)
Dialytic treatment >12 months (%)2182
(70)(88)

BMI, body mass index; CKD, chronic kidney disease; DM, Diabetes Mellitus; FFM, fat free mass; FFMI, fat free mass index; FM, fat mass; FMI, fat mass index; HD, hemodialysis; OH, overhydration; PA, phase angle; PD, peritoneal dialysis; SAH, Systemic Arterial Hypertension. Data presented as mean ± SD (minimum value to maximum value) or in %. Values with different letters in the same line between BMI subgroups, PD and HD groups are significantly different, p<0.05 (ANOVA). 1According to the obtained PA and the cut-off points proposed by Kuchnia and collaborators [24]. 2Data analyzed with unpaired t test, PD vs HD, ***p<0.001. FFM, FFMI, FM, FMI, OH and PA data from multifrequency bioelectrical impedance spectroscopy.

As groups have differences in age and sex distribution, we evaluated the association of age and sex with body composition by Pearson’s correlation: in the non-CKD group, age did not correlated with BMI, FFMI or FMI (p>0.05), but sex had a correlation coefficient of 0.60 with FFMI and of 0.48 with FMI; for the PD group, sex was not correlated (p>0.05), but age had a correlation of 0.15 with BMI, -0.22 with FFMI, and 0.19 with FMI; for HD, sex had a correlation of 0.24 with FFMI and 0.15 with FMI; age was correlated with FFMI (-0.11). Therefore, the greater FM and FMI and lower FFM and FFMI observed in CKD when compared with the non-CKD group are partially explained by sex and age differences given the observed correlation coefficients in each group.

Almost 80% of the PD group and 40% of HD group had nutritional impairment. Hyperhydration was more common in PD and dehydration in HD group. SAH affected more than half of CKD patients and DM was more common among HD patients. Residual diuresis was higher in the PD group with 7% anuric, 7% oliguric, and 86% with residual diuresis. For the HD group, the same classification was 62, 15, and 23%, respectively. Kt/V was greater in PD and the duration of dialytic treatment was longer in the HD group.

Concerning agreement between BIS and SFBIA, in the non-CKD group (see table 2), SFBIA underestimated resistance (R), reactance (Xc), and FM, and overestimated ECW and FFM. For the underweight subgroup, the greatest difference occurred for ECW, FFM, and FM, and the best agreement was for TBW and ICW, which did not show difference between devices. For normal weight, FFM, ICW, and FM had the greatest differences and ECW had the best agreement. For overweight, the greatest differences were for FFM and FM, and the best agreement for ECW; PA and TBW did not show difference between devices. For obese, FM and FFM had the greatest differences, ECW had the best agreement, and TBW and ICW did not show a difference between devices. For PD group (see table 3), SFBIA underestimated FM and overestimated TBW, ECW, ICW, and FFM. The greatest differences were for FFM and FM, and the best agreement for TBW; R, Xc, and PA did not show a difference between devices. For the HD group (see table 3), SFBIA underestimated R, Xc, and FM and overestimated TBW, ECW, and FFM. The greatest differences were for FFM and FM, the best agreement for FFM and TBW, and PA and ICW did not show a difference between devices.

Statistics of BIS vs SFBIA data in non-CKD BMI stratified subgroup

Underweight subjects (n=40)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)848±74596±103-0.02-0.12252+134 (35.5+18.9)209 to 294 (29 to 42)-10513
Xc (ohm)86±9.363±9.5-0.03-0.1223+14 (31.1+18.1)19 to 28 (25 to 37)-4.651
PA ()5.8±0.56.1±0.60.120.09-0.3+0.8 (-4.8+12.6)-0.5 to -0.05 (-8.9 to -0.7)-1.81.2
TBW (L)27±3.930±4.10.38**0.47**-3.4+4.1 (-11.7+14.3)-4.7 to -2 (-16 to -7.1)-114.7
ECW (L)11±1.414±2.20.20*0.47**-2.9+2 (-22.8+14.8)-3.6 to -2.3 (-28 to -18)-6.80.9
ICW (L)16±2.616±1.90.45**0.44**-0.4+2.5 (-3.1+14.8)-1.2 to 0.4 (-7.9 to 1.7)-5.24.4
FFM (kg)34±6.343±4.80.26*0.59**-9.1+5.1 (-24.4+13.9)-11 to -7.5 (-29 to -20)-191
FM (kg)14±45±4.40.07*0.27*8.8+5.1 (81+202.4)7.2 to 10 (15 to 147)-1.119
Normal weight subjects (n=120)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)718±99621±97-0.02-0.0597+141 (14.6+20.6)71 to 122 (11 to 18)-180374
Xc (ohm)82±9.663±8.90.040.1319+12 (25.8+16.9)16 to 21 (23 to 29)-5.343
PA ()6.6±0.85.9±0.50.100.170.7+0.9 (11.1+14.1)0.5 to 0.9 (8.6 to 14)-12.5
TBW (L)35±7.332±4.40.51**0.62**2.1+5.7 (4.9+16.7)1.0 to 3.1 (1.8 to 7.9)-9.113
ECW (L)14±2.616±2.40.58**0.66**-1.3+2.1 (-9.4+14.3)-1.7 to -0.9 (-12 to -6.8)-5.42.7
ICW (L)20±4.817±20.27*0.56**3.4+4 (16.2+19.4)2.7 to 4.1 (13 to 20)-4.411
FFM (kg)43±1147±5.60.52**0.71***-3.6+8.5 (-10.9+20)-5.2 to -2.1 (-15 to -7.2)-2013
FM (kg)21±7.118±6.50.21*0.25*3.6+8.3 (18.8+50.4)2.1 to 5.1 (9.8 to 28)-1320
Overweight subjects (n=118)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)650±78547±1020.010.02102±128 (18±22)79 to 126 (14 to 22)-148352
Xc (ohm)77±962±8.30.01-0.0215±12 (21±18)12 to 17 (18 to 24)-9.639
PA ()6.8±0.86.6±0.90.010.010.2±1.2 (3±18)-0.03 to 0.4 (-0.4 to 6.3)-2.22.6
TBW (L)38±7.737±60.52**0.52**0.8±6.8 (1.4±18)-0.4 to 2.1 (-1.8 to 4.7)-1314
ECW (L)16±2.817±2.80.65**0.70***-0.9±2.2 (-6.1±13)-1.4 to -0.6 (-8.4 to -3.7)-5.23.3
ICW (L)22±5.120±3.50.30**0.34**1.8±5.1 (7.4±23)0.9 to 2.8 (3.1 to 12)-8.112
FFM (kg)45±1355±8.90.31**0.46**-9.5±12 (-21±24)-12 to -7.4 (-26 to -17)-3213
FM (kg)34±9.224±5.7-0.07*-0.13*9.6±11 (31±41)7.5 to 12 (24 to 39)-1332
Obese subjects (n=108)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95% CI Biasc (%)dLowerUpper
R (ohm)596±77482±530.070.19114±85 (20.8+14.8)98 to 130 (17.9 to 23.6)-52280
Xc (ohm)71±9.361±6.9-0.01-0.019.8±12 (14.5+17.4)8 to 12 (11.2 to 17.9)-1333
PA ()6.8±0.87.2±0.60.01-0.05-0.4±1 (-5.7+15.3)-0.6 to -0.2 (-8.7 to -2.8)-2.51.7
TBW (L)42±8.242±5.40.70***0.77***-0.6±5.4 (-2.4+12.5)-1.6 to 0.4 (-4.8 to 0.01)-119.9
ECW (L)18±3.119±2.90.79***0.82***-0.8±1.9 (-4.5+9.7)-1.2 to -0.4 (-6.4 to -2.7)-4.42.8
ICW (L)24±5.323±2.40.53**0.69**0.2±4 (-0.9+16.6)-0.5 to 1 (-4.1 to 2.3)-7.68.1
FFM (kg)46±12.964±8.10.26*0.71***-18±9.2 (-36.4+20.5)-20 to -16 (-40.3 to -32.5)-36-0.5
FM (kg)52±11.533±6.70.16*0.61**19±9.1 (43.3+18.7)17.2 to 20.7 (39.7 to 46.9)137

BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICC, Intraclass Correlation Coefficient; ICW, intracellular water; PA, phase angle; r, Pearson correlation coefficient; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; Xc, reactance. Data presented as mean ± SD or minimum to maximum value. ICC, *p<0.05, **p<0.01 BIS vs SFBIA. r, *p<0.05, **p<0.01 BIS vs SFBIA. aMean error between BIS and SFBIA: BIS – SFBIA. bMean percentage error between BIS and SFBIA: Bias/[(BIS + SFBIA)/2] X 100. c95%CI of difference between BIS and SFBIA: BIS – SFBIA. d95%CI of difference between BIS and SFBIA (%): Bias/[(BIS + SFBIA)/2] X 100. 95%CI that include zero are unbiased.

Statistics of BIS vs SFBIA data in CKD subjects (PD and HD subgroups)

PD subgroup (n=30)
Bland-Altman
95% limits of agreement
Data analysed BIS SFBIA ICC r Biasa (%)b95%CI Biasc (%)dLower Upper
R (ohm)533±83532±830.030.041±115 (0.2±21)42 to 44 (7.5 to 8)-224226
Xc (ohm)44±1548±14-0.16-0.2-4±22 (-9±47)-12 to 4.4 (-27 to 8.4)-4840
PA () TBW (L)4.7±1.1 34±5.45.1±1 38±6.4-0.23 0.59**-0.2 0.75***-0.5±1.6 (-10±34) -4.2±4.2 (-11±11)-1.1 to 0.15 (-23 to 2.7) -5.7 to -2.6 (-16 to -7.4)-3.7 -122.7 4.1
ECW (L)17±3.319±3.20.47**0.52**-1.4±3.2 (-8.3±19)-2.6 to -0.2 (-15 to -1.4)-7.74.9
ICW (L)17±2.720±3.90.40**0.58**-2.8±3.2 (-14±16)-3.9 to -1.6 (-20 to -1.2)-93.4
FFM (kg)34±6.649±8.90.50**0.79***-15±8.3 (-36±17)-18 to -12 (-43 to -30)-311.3
FM (kg)31±1219±120.14*0.44**11±7.7 (95±257)7.7 to 13 (1.0 to 191)-4.526
HD subgroup (n=93)
Bland-Altman
95% limits of agreement
DataBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
analysed
R (ohm)730±128606±103-0.03-0.05124±168 (18±25)90 to 159 (13 to 23)-206454
Xc (ohm)78±2268±170.18*0.1610±25 (13±38)5.2 to 16 (5.3 to 21)-4060
PA ()6.1±1.26.4±1.30.050.07-0.3±1.7 (-5.3±29)-0.7 to 0.1 (-11 to 0.6)-3.73
TBW (L)33±6.936±5.70.64**0.71***-2.6±5 (-8.5±14)-3.7 to -1.6 (-11 to -5.6)-127.1
ECW (L)14±3.217±3.10.38**0.51**-2.6±3.1 (-18±19)-3.3 to -2 (-21 to -14)-8.83.5
ICW (L)19±4.219±3.70.68**0.68**-0.01±3.2 (-0.7±17)-0.7 to 0.6 (-4.1 to 2.8)-6.36.2
FFM (kg)38±9.749±7.90.65**0.85***-11±8.2 (-27±20)-13 to -9.3 (-31 to -23)-275.1
FM (kg)34±1623±130.32**0.58**11±8.2 (45±44)9.5 to 13 (36 to 54)-527

BIS, multifrequency bioelectrical impedance spectroscopy; CKD, chronic kidney disease; ECW, extracellular water; FFM, fat free mass; FM, fat mass; HD, hemodialysis; ICC, Intraclass Correlation Coefficient; ICW, intracellular water; PA, phase angle; PD, peritoneal dialysis; r, Pearson correlation coefficient; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; Xc, reactance. Data presented as mean ± SD or minimum to maximum value. ICC, *p<0.05, **p<0.01 BIS vs SFBIA. r, *p<0.05, **p<0.01, ***p<0.001 BIS vs SFBIA. aMean error between BIS and SFBIA: BIS – SFBIA. bMean percentage error between BIS and SFBIA: Bias/[(BIS + SFBIA)/2] X 100. c95%CI of difference between BIS and SFBIA: BIS – SFBIA. d95%CI of difference between BIS and SFBIA (%): Bias/[(BIS + SFBIA)/2] X 100. 95%CI that include zero are unbiased.

For all variables in all groups, the limits of agreement were very large; data generated by SFBIA and BIS are not interchangeable. In addition, FM had the highest difference and limits of agreement, and the lowest correlation and agreement coefficients. In addition, a proportional agreement was observed as the difference between devices were greater in extreme values of BMI or as BMI increased (see Fig. 1) and agreement decreased in extremes values of water imbalance or as OH increased (see Fig. 2).

Figure 1

Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with BMI. Data analyzed only for BMI subgroups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM. Circle: underweight; Square: normal weight; Trapezium: overweight; Triangle: obese.

Figure 2

Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with OH. Data analyzed only for CKD groups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; CKD, chronic kidney disease; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; OH, overhydration state; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM.

Discussion

Body composition is important given its role in survival, clinical outcomes, quality of life, and risk of mortality [5,31]. Although the existence of reference methods for body composition analyze, the low accessibility and high costs direct the efforts for bedside procedures. However, it is still unclear which bedside tool is most useful to estimate body composition and hydration status in epidemiological studies or in-patient groups, specifically obese and CKD subjects. Thus, bioelectrical impedance is a promising tool for body composition analyze, but whether the different technologies and mathematical procedures in bioelectrical devices generate similar results needs clarification.

The great differences and wide limits of agreement found in this study indicate that the results obtained with both tested devices are not interchangeable, as concluded by others [32,33].

The difference between bioimpedance devices increased with increasing BMI or were higher in BMI extremes, showing an influence of body size on measurements. As shown in the present study, the increase in BMI was due to an increase in FM, standing out as an interfering factor. Some studies evaluated the ability of BIS and SFBIA to measure body fluid or body composition compared with reference methods and observed systematic errors positively correlated with BMI [34].

Due to these errors, new equations for estimating water content and body composition by BIS were developed [10,13]; these mathematical models promised a better fit with body size as a correction for BMI is applied [9]. In the present study, such mathematical innovation was applied and partly explained the broad limits of agreement between BIS and SFBIA.

In addition, the differences between devices were higher in water imbalance status. SFBIA has as a principle that ICW-to-ECW ratio is constant with no variation of specific resistivity across different tissues [35]. However, specific resistivity is related to electrolyte concentration [35] as well as ICW and ECW distribution, factors altered by nutritional status and in disease state, as in CKD and obesity [8,14]. SFBIA has a single frequency of 50 kHz and it is unable to penetrate the cell membrane and properly compute ICW. This is the major limitation for adequately measuring TBW [11,36], ICW, and ECW as well as differentiate one parameter from another, interfering in FFM predictive capacity and overestimating fat free tissue [32].

On the other hand, the Cole model and Hanai mixture theory are mathematical models shown to best describe the physiological alteration in tissues bioelectric properties [10]. Thus, the BIS approach, with high and low frequencies, can directly measure ICW, ECW, and TBW [8,9,35]. However, BIS is based on some principles not always respected across the range of body composition, especially in states of hyper-hydration and excess adiposity [37]; many constants are employed, such as fixed values for specific resistivity of ECW and ICW compartments, body density, and shape [9,10].

Thus, these limiting factors present in each equipment but with different natures can justify the wide limits of agreement between the devices, as well as the greater differences in OH, body size, and FM extremes.

PD had older individuals, as it was shown by the Brazilian National Base in Renal Substitutive Therapies [38]. SAH and DM, main risk factors for CKD [14], were the most prevalent diseases among individuals with CKD, corroborating findings from the literature [39,40].

In non-CKD subgroups, the high BMI was largely due to the participation of FM, as observed by others [41]; a worrying information considering the young age of the group and the cardiometabolic risks that the excess body fat can exert. Regarding body composition of individuals in PD and HD, an excess FM and low FFM suggest the presence of sarcopenia, obesity, and sarcopenic obesity. The prevalence of sarcopenia in renal population in dialysis therapy varies from 20 to 44% in CKD final stages [42,43], and around 10% in the CKD under conservative treatment [44].

This prevalence is much higher than that observed in the general population [45] and in patients with early CKD stages, suggesting that the loss of muscle mass increases as renal function decreases [1].

This deleterious body composition of CKD groups can explain the high percentage of individuals with low PA values, predicting a worse clinical prognosis; PA is considered a marker of cellular integrity and associated with nutritional status. It is also an independent risk factor for long-term mortality [46]. Advanced age is a risk factor for sarcopenia and nutritional impairment [47,48] and hyperhydration is associated with inflammation and increased risk of mortality [49].

The guidelines published by the National Kidney Foundation [50] suggest that the adequacy of dialysis treatment should be interpreted considering not only the clearance of small solutes, but also a careful analyze that encompasses several aspects within each nutritional status and fluid volume. Thus, patients in PD and HD here evaluated presented nutritional risk either due to compromised body composition or to presence of dehydration and hyperhydration status [49].

This study has several strengths and limitations. All measurements were standardized and the adherence to the protocol was verified prior to measurements. The choice of predictive equations applied to raw data from BIS and SFBIA was based on the analyze of the greatest similarity with the original sample characteristics, as suggested by Mulasi and collaborators [12], being a way to improve accuracy. The evaluation of the agreement of body size, FM, and water imbalance measures between the devices with a deep statistical analyze allowing collective and individual assessment, best detailed the main interfering factors for agreement between methods. Also, individuals from PD and HD groups achieve clinical stability after 3 months on dialysis therapy and the majority remain for more than one year in renal replacement therapy [14]. However, the limitation of this study is the lack of a reference method for body composition and water content data. Thus, it is not possible to indicate which device is the most reliable.

Conclusion

SFBIA and BIS generated data that are not interchangeable. This study highlights the limitations of both technologies showing that body size, fat mass, and hydration status are interfering factors in the results and influenced the differences between methods. The limitations in BIS and SFBIA should be considered when assessing body composition and hydration status especially in obese individuals and in those with water imbalance status, such as renal patients. Future studies are needed to improve these limiting factors.

Figure 1

Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with BMI. Data analyzed only for BMI subgroups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM. Circle: underweight; Square: normal weight; Trapezium: overweight; Triangle: obese.
Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with BMI. Data analyzed only for BMI subgroups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM. Circle: underweight; Square: normal weight; Trapezium: overweight; Triangle: obese.

Figure 2

Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with OH. Data analyzed only for CKD groups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; CKD, chronic kidney disease; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; OH, overhydration state; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM.
Regression analyze between BIS and SFBIA bias (BIS-SFBIA) with OH. Data analyzed only for CKD groups. BIS, multifrequency bioelectrical impedance spectroscopy; BMI, body mass index; CKD, chronic kidney disease; ECW, extracellular water; FFM, fat free mass; FM, fat mass; ICW, intracellular water; PA, phase angle; R, resistance; SFBIA, single-frequency bioelectrical impedance; TBW, total body water; OH, overhydration state; Xc, reactance. (a) R; (b) Xc; (c) PA; (d) TBW; (e) ICW; (f) ECW; (g) FFM; (h) FM.

Descriptive data for non-CKD subjects stratified in BMI subgroups and for CKD patients stratified in PD and HD subgroups

BMI<18.518.5≤BMI<2525≤BMI<30BMI≥30PDHD
n401201181083093
Women (%)326259521142
(80)(51)(50)(48)(37)(45)
Age (years)26±4.2a29±3.9a29±4.6a30±5a52±19b47±13c
(20 to 38)(20 to 40)(20 to 40)(20 to 40)(15 to 81)(20 to 76)
Weight (kg)48±4.9a64±9.4b79±9.8c98±12d68±13be72±17e
(39 to 60)(45 to 87)(59 to 109)(71 to 124)(38 to 93)(42 to 137)
BMI (kg/m2)18±0.7a22±1.8b27±1.4c34±2.7d24±3.4e26±5e
(15 to 18)(19 to 25)(25 to 30)(30 to 40)(16 to 32)(17 to 44)
OH (L)-0.1±0.4a-0.3±0.7a-0.5±0.9ab-0.8±0.9b2.1±2.2c-0.9±1.9b
(-1.2 to 0.9)(-1.9 to 1.5)(-3.1 to 2.1)(-3 to 1.8)(-0.7 to 6.2)(-5 to 6.0)
OH>1.1 L (%)00431710
(0)(0)(3)(3)(57)(11)
OH<-1.1 L (%)0142942049
(0)(12)(25)(39)(0)(53)
FFM (kg)34±6.3a43±11b45±13b46±13b34±6.6a38±9.7a
(26 to 51)(26 to 70)(27 to 76)(25 to 76)(24 to 56)(20 to 60)
FFMI (kg/m2)12±1.5a15±2.8b15±3.1b15±3.1b12±1.8a14±2.6a
(10 to 16)(9 to 22)(10 to 23)(9 to 23)(8 to 16)(8 to 20)
FM (kg)14±4a21±7.1b34±9.3c52±12d30±12c34±16c
(4 to 21)(3 to 37)(11 to 57)(24 to 83)(9 to 56)(2 to 99)
FMI (kg/m2)5±1.5a7±2.7b12±3.5c18±4.6d11±4.2c12±5.6c
(1 to 8)(1 to 13)(4 to 19)(8 to 29)(4 to 19)(1 to 29)
PA ()5.8±0.5a6.6±0.8b6.8±0.8b6.8±0.8b4.7±1.1c6.1±1.2a
(4.8 to 7)(4.8 to 8.2)(5.3 to 9)(5 to 8.9)(2.8 to 7.1)(3 to 9.1)
Impairment Nutritional status (%)147422333
(10)(6)(3)(2)(76)(36)
DM (%)00001061
(0)(0)(0)(0)(33)(66)
SAH (%)00001961
(0)(0)(0)(0)(63)(66)
Residual Diuresis (ml)2937±680***170±330***
(50 to 2000)(0 to 2000)
Kt/V12.6±0.9***1.5±0.3***
(1.4 to 4.5)(1 to 2.5)
Duration of dialytic treatment33±32***63±48***
(months)2(3 to 144)(5 to 264)
Dialytic treatment >12 months (%)2182
(70)(88)

Statistics of BIS vs SFBIA data in CKD subjects (PD and HD subgroups)

PD subgroup (n=30)
Bland-Altman
95% limits of agreement
Data analysed BIS SFBIA ICC r Biasa (%)b95%CI Biasc (%)dLower Upper
R (ohm)533±83532±830.030.041±115 (0.2±21)42 to 44 (7.5 to 8)-224226
Xc (ohm)44±1548±14-0.16-0.2-4±22 (-9±47)-12 to 4.4 (-27 to 8.4)-4840
PA () TBW (L)4.7±1.1 34±5.45.1±1 38±6.4-0.23 0.59**-0.2 0.75***-0.5±1.6 (-10±34) -4.2±4.2 (-11±11)-1.1 to 0.15 (-23 to 2.7) -5.7 to -2.6 (-16 to -7.4)-3.7 -122.7 4.1
ECW (L)17±3.319±3.20.47**0.52**-1.4±3.2 (-8.3±19)-2.6 to -0.2 (-15 to -1.4)-7.74.9
ICW (L)17±2.720±3.90.40**0.58**-2.8±3.2 (-14±16)-3.9 to -1.6 (-20 to -1.2)-93.4
FFM (kg)34±6.649±8.90.50**0.79***-15±8.3 (-36±17)-18 to -12 (-43 to -30)-311.3
FM (kg)31±1219±120.14*0.44**11±7.7 (95±257)7.7 to 13 (1.0 to 191)-4.526
HD subgroup (n=93)
Bland-Altman
95% limits of agreement
DataBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
analysed
R (ohm)730±128606±103-0.03-0.05124±168 (18±25)90 to 159 (13 to 23)-206454
Xc (ohm)78±2268±170.18*0.1610±25 (13±38)5.2 to 16 (5.3 to 21)-4060
PA ()6.1±1.26.4±1.30.050.07-0.3±1.7 (-5.3±29)-0.7 to 0.1 (-11 to 0.6)-3.73
TBW (L)33±6.936±5.70.64**0.71***-2.6±5 (-8.5±14)-3.7 to -1.6 (-11 to -5.6)-127.1
ECW (L)14±3.217±3.10.38**0.51**-2.6±3.1 (-18±19)-3.3 to -2 (-21 to -14)-8.83.5
ICW (L)19±4.219±3.70.68**0.68**-0.01±3.2 (-0.7±17)-0.7 to 0.6 (-4.1 to 2.8)-6.36.2
FFM (kg)38±9.749±7.90.65**0.85***-11±8.2 (-27±20)-13 to -9.3 (-31 to -23)-275.1
FM (kg)34±1623±130.32**0.58**11±8.2 (45±44)9.5 to 13 (36 to 54)-527

Statistics of BIS vs SFBIA data in non-CKD BMI stratified subgroup

Underweight subjects (n=40)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)848±74596±103-0.02-0.12252+134 (35.5+18.9)209 to 294 (29 to 42)-10513
Xc (ohm)86±9.363±9.5-0.03-0.1223+14 (31.1+18.1)19 to 28 (25 to 37)-4.651
PA ()5.8±0.56.1±0.60.120.09-0.3+0.8 (-4.8+12.6)-0.5 to -0.05 (-8.9 to -0.7)-1.81.2
TBW (L)27±3.930±4.10.38**0.47**-3.4+4.1 (-11.7+14.3)-4.7 to -2 (-16 to -7.1)-114.7
ECW (L)11±1.414±2.20.20*0.47**-2.9+2 (-22.8+14.8)-3.6 to -2.3 (-28 to -18)-6.80.9
ICW (L)16±2.616±1.90.45**0.44**-0.4+2.5 (-3.1+14.8)-1.2 to 0.4 (-7.9 to 1.7)-5.24.4
FFM (kg)34±6.343±4.80.26*0.59**-9.1+5.1 (-24.4+13.9)-11 to -7.5 (-29 to -20)-191
FM (kg)14±45±4.40.07*0.27*8.8+5.1 (81+202.4)7.2 to 10 (15 to 147)-1.119
Normal weight subjects (n=120)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)718±99621±97-0.02-0.0597+141 (14.6+20.6)71 to 122 (11 to 18)-180374
Xc (ohm)82±9.663±8.90.040.1319+12 (25.8+16.9)16 to 21 (23 to 29)-5.343
PA ()6.6±0.85.9±0.50.100.170.7+0.9 (11.1+14.1)0.5 to 0.9 (8.6 to 14)-12.5
TBW (L)35±7.332±4.40.51**0.62**2.1+5.7 (4.9+16.7)1.0 to 3.1 (1.8 to 7.9)-9.113
ECW (L)14±2.616±2.40.58**0.66**-1.3+2.1 (-9.4+14.3)-1.7 to -0.9 (-12 to -6.8)-5.42.7
ICW (L)20±4.817±20.27*0.56**3.4+4 (16.2+19.4)2.7 to 4.1 (13 to 20)-4.411
FFM (kg)43±1147±5.60.52**0.71***-3.6+8.5 (-10.9+20)-5.2 to -2.1 (-15 to -7.2)-2013
FM (kg)21±7.118±6.50.21*0.25*3.6+8.3 (18.8+50.4)2.1 to 5.1 (9.8 to 28)-1320
Overweight subjects (n=118)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95%CI Biasc (%)dLowerUpper
R (ohm)650±78547±1020.010.02102±128 (18±22)79 to 126 (14 to 22)-148352
Xc (ohm)77±962±8.30.01-0.0215±12 (21±18)12 to 17 (18 to 24)-9.639
PA ()6.8±0.86.6±0.90.010.010.2±1.2 (3±18)-0.03 to 0.4 (-0.4 to 6.3)-2.22.6
TBW (L)38±7.737±60.52**0.52**0.8±6.8 (1.4±18)-0.4 to 2.1 (-1.8 to 4.7)-1314
ECW (L)16±2.817±2.80.65**0.70***-0.9±2.2 (-6.1±13)-1.4 to -0.6 (-8.4 to -3.7)-5.23.3
ICW (L)22±5.120±3.50.30**0.34**1.8±5.1 (7.4±23)0.9 to 2.8 (3.1 to 12)-8.112
FFM (kg)45±1355±8.90.31**0.46**-9.5±12 (-21±24)-12 to -7.4 (-26 to -17)-3213
FM (kg)34±9.224±5.7-0.07*-0.13*9.6±11 (31±41)7.5 to 12 (24 to 39)-1332
Obese subjects (n=108)
Bland-Altman
95% limits of agreement
Data analysedBISSFBIAICCrBiasa (%)b95% CI Biasc (%)dLowerUpper
R (ohm)596±77482±530.070.19114±85 (20.8+14.8)98 to 130 (17.9 to 23.6)-52280
Xc (ohm)71±9.361±6.9-0.01-0.019.8±12 (14.5+17.4)8 to 12 (11.2 to 17.9)-1333
PA ()6.8±0.87.2±0.60.01-0.05-0.4±1 (-5.7+15.3)-0.6 to -0.2 (-8.7 to -2.8)-2.51.7
TBW (L)42±8.242±5.40.70***0.77***-0.6±5.4 (-2.4+12.5)-1.6 to 0.4 (-4.8 to 0.01)-119.9
ECW (L)18±3.119±2.90.79***0.82***-0.8±1.9 (-4.5+9.7)-1.2 to -0.4 (-6.4 to -2.7)-4.42.8
ICW (L)24±5.323±2.40.53**0.69**0.2±4 (-0.9+16.6)-0.5 to 1 (-4.1 to 2.3)-7.68.1
FFM (kg)46±12.964±8.10.26*0.71***-18±9.2 (-36.4+20.5)-20 to -16 (-40.3 to -32.5)-36-0.5
FM (kg)52±11.533±6.70.16*0.61**19±9.1 (43.3+18.7)17.2 to 20.7 (39.7 to 46.9)137

Sharma D, Hawkins M, Abramowitz MK. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clin J Am Soc Nephrol. 2014;9:2079-2788. https://doi.org/10.2215/CJN.02140214SharmaDHawkinsMAbramowitzMKAssociation of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United StatesClin J Am Soc Nephrol2014920792788https://doi.org/10.2215/CJN.0214021410.2215/CJN.02140214425539625392147Search in Google Scholar

Johansen KL, Lee C. Body composition in chronic kidney disease. Curr Opin Nephrol Hypertens. 2015;24:268-275. https://doi.org/10.1097/MNH.0000000000000120JohansenKLLeeCBody composition in chronic kidney diseaseCurr Opin Nephrol Hypertens201524268275https://doi.org/10.1097/MNH.000000000000012010.1097/MNH.0000000000000120477854525887900Search in Google Scholar

Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, et al. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol. 2014;25:381-389. https://doi.org/10.1681/ASN.2013040431JohansenKLDalrympleLSDelgadoCKaysenGAKornakJGrimesBAssociation between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special studyJ Am Soc Nephrol201425381389https://doi.org/10.1681/ASN.201304043110.1681/ASN.2013040431390456724158987Search in Google Scholar

Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138-1145. https://doi.org/10.1056/NEJMsr043743OlshanskySJPassaroDJHershowRCLaydenJCarnesBABrodyJA potential decline in life expectancy in the United States in the 21st centuryN Engl J Med200535211381145https://doi.org/10.1056/NEJMsr04374310.1056/NEJMsr04374315784668Search in Google Scholar

Earthman CP. Body composition tools for assessment of adult malnutrition at the bedside: A tutorial on research considerations and clinical applications. JPEN J Parenter Enteral Nutr. 2015;39:787-822. https://doi.org/10.1177/0148607115595227EarthmanCPBody composition tools for assessment of adult malnutrition at the bedside: A tutorial on research considerations and clinical applicationsJPEN J Parenter Enteral Nutr201539787822https://doi.org/10.1177/014860711559522710.1177/014860711559522726287016Search in Google Scholar

Sergi G, Trevisan C, Veronese N, Lucato P, Manzato E. Imaging of sarcopenia. Eur J Radiol. 2016;85:1519-1524. https://doi.org/10.1016/j.ejrad.2016.04.009SergiGTrevisanCVeroneseNLucatoPManzatoEImaging of sarcopeniaEur J Radiol20168515191524https://doi.org/10.1016/j.ejrad.2016.04.00910.1016/j.ejrad.2016.04.00927117135Search in Google Scholar

Lukaski HC. Evolution of bioimpedance: a circuitous journey from estimation of physiological function to assessment of body composition and a return to clinical research. Eur J Clin Nutr. 2013;67:2-9. https://doi.org/10.1038/ejcn.2012.149LukaskiHCEvolution of bioimpedance: a circuitous journey from estimation of physiological function to assessment of body composition and a return to clinical researchEur J Clin Nutr20136729https://doi.org/10.1038/ejcn.2012.14910.1038/ejcn.2012.14923299867Search in Google Scholar

Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Composition of the ESPEN Working Group Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr. 2004;23:1226-1243. https://doi.org/10.1016/j.clnu.2004.06.004KyleUGBosaeusIDe LorenzoADDeurenbergPEliaMGómezJMComposition of the ESPEN Working Group Bioelectrical impedance analysis—part I: review of principles and methodsClin Nutr20042312261243https://doi.org/10.1016/j.clnu.2004.06.00410.1016/j.clnu.2004.06.00415380917Search in Google Scholar

Matthie JR. Bioimpedance measurements of human body composition: critical analysis and outlook. Expert Rev Med Devices. 2008;5:239-261. https://doi.org/10.1586/17434440.5.2.239MatthieJRBioimpedance measurements of human body composition: critical analysis and outlookExpert Rev Med Devices20085239261https://doi.org/10.1586/17434440.5.2.23910.1586/17434440.5.2.23918331184Search in Google Scholar

Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006;27:921-933. https://doi.org/10.1088/0967-3334/27/9/012MoisslUMWabelPChamneyPWBosaeusILevinNWBosy-WestphalABody fluid volume determination via body composition spectroscopy in health and diseasePhysiol Meas200627921933https://doi.org/10.1088/0967-3334/27/9/01210.1088/0967-3334/27/9/01216868355Search in Google Scholar

Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30:1257-1269. https://doi.org/10.1016/j.medengphy.2008.06.009JaffrinMYMorelHBody fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methodsMed Eng Phys20083012571269https://doi.org/10.1016/j.medengphy.2008.06.00910.1016/j.medengphy.2008.06.00918676172Search in Google Scholar

Mulasi U, Kuchnia AJ, Cole AJ, Earthman CP. Bioimpedance at the bedside: current applications, limitations and opportunities. Nutr Clin Pract. 2015;30:180-193. https://doi.org/10.1177/0884533614568155MulasiUKuchniaAJColeAJEarthmanCPBioimpedance at the bedside: current applications, limitations and opportunitiesNutr Clin Pract201530180193https://doi.org/10.1177/088453361456815510.1177/088453361456815525613832Search in Google Scholar

Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80-89. https://doi.org/10.1093/ajcn/85.1.80ChamneyPWWabelPMoisslUMMüllerMJBosy-WestphalAKorthOA whole-body model to distinguish excess fluid from the hydration of major body tissuesAm J Clin Nutr2007858089https://doi.org/10.1093/ajcn/85.1.8010.1093/ajcn/85.1.8017209181Search in Google Scholar

Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl 2013;3:1-150.Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO2012clinical practice guideline for the evaluation and management of chronic kidney diseaseKidney Inter Suppl 201331150Search in Google Scholar

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;1:81-90. https://doi.org/10.2337/dc14-S081American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201418190https://doi.org/10.2337/dc14-S08110.2337/dc14-S08124357215Search in Google Scholar

McCormack T, Krause T, O'Flynn N. Management of hypertension in adults in primary care: NICE guideline. Br J Gen Pract. 2012;62:163–164. https://doi.org/10.3399/bjgp12X630232McCormackTKrauseTO'FlynnNManagement of hypertension in adults in primary care: NICE guidelineBr J Gen Pract201262163164https://doi.org/10.3399/bjgp12X63023210.3399/bjgp12X630232328981922429432Search in Google Scholar

Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care. 2002; 8:509–514. https://doi.org/10.1097/00075198-200212000-00005KellumJALevinNBoumanCLameireNDeveloping a consensus classification system for acute renal failureCurr Opin Crit Care20028509514https://doi.org/10.1097/00075198-200212000-0000510.1097/00075198-200212000-0000512454534Search in Google Scholar

Heymsfield SB. Anthropometric measurements: application in hospitalized patients. Infusionstherapie. 1990;17:48-51.HeymsfieldSBAnthropometric measurements: application in hospitalized patientsInfusionstherapie199017485110.1159/0002225522119348Search in Google Scholar

World Health Organization. Physical status: the use and interpretation of anthropometry, report of a WHO Expert Committee. Geneva, Switzerland: WHO Technical Report Series 854. 1995.World Health OrganizationPhysical status: the use and interpretation of anthropometry, report of a WHO Expert CommitteeGeneva, SwitzerlandWHO Technical Report Series 8541995Search in Google Scholar

Sergi G, Bussolotto M, Perini P, Calliari I, Giantin V, Ceccon A, et al. Accuracy of bioelectrical impedance analysis in estimation of extracellular spaces in healthy subjects and in fluid retention. Ann Nutr Metab. 1994;38:158-165. https://doi.org/10.1159/000177806SergiGBussolottoMPeriniPCalliariIGiantinVCecconAAccuracy of bioelectrical impedance analysis in estimation of extracellular spaces in healthy subjects and in fluid retentionAnn Nutr Metab199438158165https://doi.org/10.1159/00017780610.1159/0001778067979169Search in Google Scholar

Sun SS, Chumlea WC, Heymsfield SB, Lukaski HC, Schoeller D, Friedl K, et al. Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr. 2003;77:331-340. https://doi.org/10.1093/ajcn/77.2.331SunSSChumleaWCHeymsfieldSBLukaskiHCSchoellerDFriedlKDevelopment of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveysAm J Clin Nutr200377331340https://doi.org/10.1093/ajcn/77.2.33110.1093/ajcn/77.2.33112540391Search in Google Scholar

Deurenberg P, Weststrate JA, Hautvast JG. Changes in fat free mass during weight loss measured by bioelectrical impedance and by densitometry. Am J Clin Nutr. 1989;49:33-36. https://doi.org/10.1093/ajcn/49.1.33DeurenbergPWeststrateJAHautvastJGChanges in fat free mass during weight loss measured by bioelectrical impedance and by densitometryAm J Clin Nutr1989493336https://doi.org/10.1093/ajcn/49.1.3310.1093/ajcn/49.1.332912008Search in Google Scholar

Kushner RF, Schoeller DA. Estimation of total bod water by bioelectrical impedance analysis. Am J Clin Nutr. 1986;44:417-424. https://doi.org/10.1093/ajcn/44.3.417KushnerRFSchoellerDAEstimation of total bod water by bioelectrical impedance analysisAm J Clin Nutr198644417424https://doi.org/10.1093/ajcn/44.3.41710.1093/ajcn/44.3.4173529918Search in Google Scholar

Kuchnia AJ, Teigen LM, Cole AJ, Mulasi U, Gonzalez MC, Heymsfield SB, et al. Phase Angle and Impedance Ratio: reference cut-points from the United States National Health and Nutrition Examination Survey 1999–2004 from bioimpedance spectroscopy data. JPEN J Parenter Enteral Nutr. 2016;41:1310-1315. https://doi.org/10.1177/0148607116670378KuchniaAJTeigenLMColeAJMulasiUGonzalezMCHeymsfieldSBPhase Angle and Impedance Ratio: reference cut-points from the United States National Health and Nutrition Examination Survey 1999–2004 from bioimpedance spectroscopy dataJPEN J Parenter Enteral Nutr20164113101315https://doi.org/10.1177/014860711667037810.1177/014860711667037827670250Search in Google Scholar

Ronco C, Verger C, Crepaldi C, Pham J, De Los Ríos T, Gauly A, et al. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study). Nephrol Dial Transplant. 2015;30:849-858. https://doi.org/10.1093/ndt/gfv013RoncoCVergerCCrepaldiCPhamJDe LosRíos TGaulyABaseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)Nephrol Dial Transplant201530849858https://doi.org/10.1093/ndt/gfv01310.1093/ndt/gfv013442548025762355Search in Google Scholar

Wilk MB, Gnanadesikan R. Probability plotting methods for the analysis of data. Biometrika, Biometrika Trust. 1968;55:1-17.WilkMBGnanadesikanRProbability plotting methods for the analysis of dataBiometrika, Biometrika Trust19685511710.2307/2334448Search in Google Scholar

Pagano M, Gauvreau K. Princípios de Bioestatística. 1st ed. Sao Paulo, SP: Thomson; 2004.PaganoMGauvreauKPrincípios de Bioestatística1st edSao Paulo, SP: Thomson2004Search in Google Scholar

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. https://doi.org/10.1016/S0140-6736(86)90837-8BlandJMAltmanDGStatistical methods for assessing agreement between two methods of clinical measurementLancet19861307310https://doi.org/10.1016/S0140-6736(86)90837-810.1016/j.ijnurstu.2009.10.001Search in Google Scholar

Landis JR, Koch GG. The Measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. https://doi.org/10.2307/2529310LandisJRKochGGThe Measurement of observer agreement for categorical dataBiometrics197733159174https://doi.org/10.2307/252931010.2307/2529310Search in Google Scholar

Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radioology. 2003;227:617-622. https://doi.org/10.1148/radiol.2273011499ZouKHTuncaliKSilvermanSGCorrelation and simple linear regressionRadioology2003227617622https://doi.org/10.1148/radiol.227301149910.1148/radiol.227301149912773666Search in Google Scholar

Baracos V, Caserotti P, Earthman CP, Fields D, Gallagher D, Hall KD, et al. Advances in the science and application of body composition measurement. JPEN J Parenter Enteral Nutr. 2012;36:96-107. https://doi.org/10.1177/0148607111417448BaracosVCaserottiPEarthmanCPFieldsDGallagherDHallKDAdvances in the science and application of body composition measurementJPEN J Parenter Enteral Nutr20123696107https://doi.org/10.1177/014860711141744810.1177/0148607111417448442206622235108Search in Google Scholar

Jochen GR, Samer RA, Li L, Zhu F, Larive B, Kotanko P, et al. Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the frequent hemodialysis network (FHN) daily trial. Nephron Clin Pract. 2014;128:115-126. https://doi.org/10.1159/000366447JochenGRSamerRALiLZhuFLariveBKotankoPAgreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the frequent hemodialysis network (FHN) daily trialNephron Clin Pract2014128115126https://doi.org/10.1159/00036644710.1159/000366447442024025402657Search in Google Scholar

Yalın SF, Gulcicek S, Avci S, Erkalma Senates B, Altiparmak MR, Trabulus S, et al. Single-frequency and multi-frequency bioimpedance analysis: What is the difference? Nephrology 2018;23:438-445. https://doi.org/10.1111/nep.13042YalınSFGulcicekSAvciSErkalmaSenates BAltiparmakMRTrabulusSSingle-frequency and multi-frequency bioimpedance analysis: What is the difference? Nephrology201823438445https://doi.org/10.1111/nep.1304210.1111/nep.1304228295857Search in Google Scholar

Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG, et al. Comparison of multifrequency bioelectrical impedance analysis with dual energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005;81:74-81. https://doi.org/10.1093/ajcn/81.1.74SunGFrenchCRMartinGRYounghusbandBGreenRCXieYGComparison of multifrequency bioelectrical impedance analysis with dual energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy populationAm J Clin Nutr2005817481https://doi.org/10.1093/ajcn/81.1.7410.1093/ajcn/81.1.74Search in Google Scholar

Ellis KJ, Bell SJ, Chertow GM, Chumlea WC, Knox TA, Kotler DP, et al. Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference. Nutrition. 1999;15:874-880. https://doi.org/10.1016/S0899-9007(99)00147-1EllisKJBellSJChertowGMChumleaWCKnoxTAKotlerDPBioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment ConferenceNutrition199915874880https://doi.org/10.1016/S0899-9007(99)00147-110.1016/S0899-9007(99)00147-1Search in Google Scholar

Seoane F, Abtahi S, Abtahi F, Ellegård L, Johannsson G, Bosaeus I, et al. Mean expected error in prediction of total body water: a true accuracy comparison between bioimpedance spectroscopy and single frequency regression equations. BioMed Res Int. 2015. https://doi.org/10.1155/2015/656323SeoaneFAbtahiSAbtahiFEllegårdLJohannssonGBosaeusIMean expected error in prediction of total body water: a true accuracy comparison between bioimpedance spectroscopy and single frequency regression equationsBioMed Res Int2015https://doi.org/10.1155/2015/65632310.1155/2015/656323446828526137489Search in Google Scholar

Popovic V, Zerahn B, Heaf JG. Comparison of dual energy X-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patients. J Ren Nutr. 2017;27:355-363. https://doi.org/10.1053/j.jrn.2017.03.003PopovicVZerahnBHeafJGComparison of dual energy X-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patientsJ Ren Nutr201727355363https://doi.org/10.1053/j.jrn.2017.03.00310.1053/j.jrn.2017.03.00328528793Search in Google Scholar

Cherchiglia ML, Machado EL, Szuster DA, Andrade EI, Assis Acúrcio Fd, Caiaffa WT, et al. Epidemiological profile of patients on renal replacement therapy in Brazil, 2000-2004. Rev Saúde Pública. 2010;44:639-649. https://doi.org/10.1590/S0034-89102010000400007CherchigliaMLMachadoELSzusterDAAndradeEIAssisAcúrcio FdCaiaffaWTEpidemiological profile of patients on renal replacement therapy in Brazil, 2000-2004Rev Saúde Pública201044639649https://doi.org/10.1590/S0034-8910201000040000710.1590/S0034-8910201000040000720676555Search in Google Scholar

Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, et al. A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients. BMC Nephrol. 2015;16:113. https://doi.org/10.1186/s12882-015-0110-9CabreraCBrunelliSMRosenbaumDAnumERamakrishnanKJensenDEA retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patientsBMC Nephrol201516113https://doi.org/10.1186/s12882-015-0110-910.1186/s12882-015-0110-9451088726197758Search in Google Scholar

Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian Chronic Dialysis Census 2014. J Bras Nefrol. 2016;38:54-61. https://doi.org/10.5935/0101-2800.20160009SessoRCLopesAAThoméFSLugonJRMartinsCT. Brazilian Chronic Dialysis Census2014J Bras Nefrol2016385461https://doi.org/10.5935/0101-2800.2016000910.5935/0101-2800.2016000927049365Search in Google Scholar

Anjos LA, Wahrlich V, Vasconcellos MT. BMR in a Brazilian adult probability sample: the Nutrition, Physical Activity and Health Survey. Public Health Nutr. 2013;17:853-860. https://doi.org/10.1017/S1368980012005381AnjosLAWahrlichVVasconcellosMTBMR in a Brazilian adult probability sample: the Nutrition, Physical Activity and Health SurveyPublic Health Nutr201317853860https://doi.org/10.1017/S136898001200538110.1017/S136898001200538123286824Search in Google Scholar

Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64-68. https://doi.org/10.1016/j.clnu.2013.04.002KimJKChoiSRChoiMJKimSGLeeYKNohJWPrevalence of and factors associated with sarcopenia in elderly patients with end-stage renal diseaseClin Nutr2014336468https://doi.org/10.1016/j.clnu.2013.04.00210.1016/j.clnu.2013.04.00223631844Search in Google Scholar

Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging. 2014;18:710-717. https://doi.org/10.1007/s12603-014-0505-5LamarcaFCarreroJJRodriguesJCBigognoFGFetterRLAvesaniCMPrevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteriaJ Nutr Health Aging201418710717https://doi.org/10.1007/s12603-014-0505-510.1007/s12603-014-0505-525226111Search in Google Scholar

Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. 2015;30:1718-1725. https://doi.org/10.1093/ndt/gfv133PereiraRACordeiroACAvesaniCMCarreroJJLindholmBAmparoFCSarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortalityNephrol Dial Transplant20153017181725https://doi.org/10.1093/ndt/gfv13310.1093/ndt/gfv13325999376Search in Google Scholar

Beaudart C, Reginster JY, Slomian J, Buckinx F, Dardenne N, Quabron A, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol. 2015;61:31-37. https://doi.org/10.1016/j.exger.2014.11.014BeaudartCReginsterJYSlomianJBuckinxFDardenneNQuabronAEstimation of sarcopenia prevalence using various assessment toolsExp Gerontol2015613137https://doi.org/10.1016/j.exger.2014.11.01410.1016/j.exger.2014.11.01425449859Search in Google Scholar

Oliveira CM, Kubrusly M, Mota RS, Silva CA, Choukroun G, Oliveira VN. The phase angle and mass body cell as markers of nutritional status in hemodialysis patients. J Ren Nutr. 2010;20:314-320. https://doi.org/10.1053/j.jrn.2010.01.008OliveiraCMKubruslyMMotaRSSilvaCAChoukrounGOliveiraVNThe phase angle and mass body cell as markers of nutritional status in hemodialysis patientsJ Ren Nutr201020314320https://doi.org/10.1053/j.jrn.2010.01.00810.1053/j.jrn.2010.01.00820303790Search in Google Scholar

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-256. https://doi.org/10.1016/j.jamda.2011.01.003FieldingRAVellasBEvansWJBhasinSMorleyJENewmanABSarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology and consequences. International working group on sarcopeniaJ Am Med Dir Assoc201112249256https://doi.org/10.1016/j.jamda.2011.01.00310.1016/j.jamda.2011.01.003337716321527165Search in Google Scholar

Dodds RM, Roberts HC, Cooper C, Sayer AA. The epidemiology of sarcopenia. J Clin Densitom. 2015;18:461-466. https://doi.org/10.1016/j.jocd.2015.04.012DoddsRMRobertsHCCooperCSayerAAThe epidemiology of sarcopeniaJ Clin Densitom201518461466https://doi.org/10.1016/j.jocd.2015.04.01210.1016/j.jocd.2015.04.012462940926073423Search in Google Scholar

Noordzij M, Jager KJ. Survival comparisons between hemodialysis and peritoneal dialysis. Nephrol Dial Transplant. 2012;27:3385-3387. https://doi.org/10.1093/ndt/gfs031NoordzijMJagerKJSurvival comparisons between hemodialysis and peritoneal dialysisNephrol Dial Transplant20122733853387https://doi.org/10.1093/ndt/gfs03110.1007/978-3-319-90760-4_3-1Search in Google Scholar

National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis. 2006;48:1-322.National Kidney FoundationKDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular AccessAm J Kidney Dis2006Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access Am J Kidney Dis. 2006481322Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo